Xuesong Wu
ORCID: 0000-0003-0093-6338Also affiliated with Kunming Medical University, Shanxi Provincial Cancer Hospital, Stomatology Hospital, UC Davis Health, Shanghai Institute of Pharmaceutical Industry, University of California, Davis
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism”.
Tahereh Setayesh, Farzam Vaziri, Xuesong Wu, Samuel Hwang, Xin Chen +2 more
Xuesong Wu, Chun‐Yi Wu, Satya P. Singh, Timothy Law, Daisuke Yamada +7 more
Yatian Yang, Zhenrui Shi, Xuesong Wu, Ruiwu Liu, Ai‐Ming Yu +2 more
Xuesong Wu, Clarissa Santos Rocha, Matthew Rolston, Emma García-Melchor, Mindy Huynh +9 more
Szu Jung Chen, Megan R. Westerland, Xuesong Wu, Samuel Hwang, Scott I. Simon +1 more
William R. Clarke, Chad A. Koplinski, Francis C. Peterson, Michael B. Dwinell, Grace Wei +6 more
Simon Vu, Xuesong Wu, Zhenrui Shi, Desiree Morris, Joshua Bloomstein +4 more